石富丽，2023年9月毕业于暨南大学，获得博士学位，随后加入李建明教授课题组进行博士后研究，研究方向聚焦于抗PANoptosis药物的发现及其靶点的探索，并开展系统的药理机制研究。

在相关领域以第一作者在Acta Pharmacologica Sinica、Pharmacological Research、International Immunopharmacology 等期刊上发表了SCI论文。并获得了博士后面上经费资助和博士后国资计划C档资助。

中药免疫药理学，靶点及机制探索

1. Fu-li Shi; Qing Li; Rong Xu; Li-sha Yuan; Ying Chen; Zi-jian Shi; Ya-ping Li; Zhi-ya Zhou; Li-hui Xu; Qing-bing Zha; Bo Hu; Xian-hui He; Dong-yun Ou-yang ; Blocking reverse electron transfer-mediated mitochondrial DNA oxidation rescues cells from PANoptosis, Acta Pharmacologica Sinica, 2024, 45(3): 594-608.

2. Fu-li Shi; Li-sha Yuan; Tak-sui Wong; Qing Li; Ya-ping Li; Rong Xu; Yi-ping You; Tao Yuan; Hong-rui zhang; Zi-jian Shi; Qing-bing Zha; Bo Hu; Xian-hui He; Dong-yun Ouyang ; Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis, Pharmacological Research, 2023, (189): 106697.

3. Fu-li Shi; Si-tao Ni; Shi-qi Luo; Bo Hu; Rong Xu; Si-ying Liu; Xiao-di Huang; Bo Zeng; Qi-qi Liang; Si-yuan Chen; Jia-hao Qiu; Xian-hui He; Qing-bing Zha; Dong-yun Ouyang ; Dimethyl fumarate ameliorates autoimmune hepatitis in mice by blocking NLRP3 inflammasome activation, International Immunopharmacology, 2022, 108: 108867.

4. Fuli Shi; Zhimin Tang; Shanshan Jiang; Zhijuan Xiong; Wansi Zhang; Yuanjun Li; Hui Lin; Zhijun Luo; Ying Ying ; AMP‐activated protein kinase β1 or β2 deletion enhances colon cancer cell growth and tumorigenesis, Acta Biochimica et Biophysica Sinica, 2022, 54(8): 1140- 1147.